生物技术公司获得高盛等机构的好评. Biotech firm receives positive ratings from Goldman Sachs and others.

创建生物医药公司 (NASDAQ:GENB) 从多家经纪公司获得了积极评级,包括高盛,坎托尔·菲茨杰拉德和古根海姆,这些机构已经分配了"购买"或"超重"的评级.价格目标范围从25美元到30美元不等. Generate Biomedicines Inc. (NASDAQ:GENB) has received positive ratings from multiple brokerage firms, including Goldman Sachs, Cantor Fitzgerald, and Guggenheim, which have assigned "buy" or "overweight" ratings with price targets ranging from $25.00 to $30.00. 生物技术公司使用机器学习和人工智能来设计新疗法, 加快药物发现. The biotechnology company uses machine learning and artificial intelligence to design novel therapeutics and accelerate drug discovery. 股票开盘时价格为12.85美元,52周的波动范围是11.00至15.32美元. The stock opened at $12.85 with a 52-week range of $11.00 to $15.32.